AgomAb Therapeutics N.V. American Depositary Shares

NASDAQ:AGMB

Biotechnology

Healthcare
$5.82 +2.48%

+$0.25 today

Market cap
$286.62M
Beta
2.62
P/E (TTM)
-7.1
EPS (TTM)
-$1.28
52W Low $8.75High $17.45

Volume 0.13M

Average 0.14M

AGMB Total Liabilities

Everything the company owes to creditors and other parties.

AgomAb Therapeutics N.V. American Depositary SharesNASDAQ: AGMB

Total Liabilities · Q3 FY2025 · quarter ended Sep 2025

Total liabilities of €18.7M in Q3 FY2025

Q3 FY2025 total liabilities was €18.7M.

Context

  • Total liabilities amounted to 11.3% of total assets at the end of Q3 FY2025.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterSep 2025
€18.7M— QoQ
Total Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Total Liabilities history

Currency unavailable · from the balance sheet

No Total Liabilities data reported for this period type.

Total Liabilities vs competitors

How AGMB compares with its peers on the latest reported figures

  • Peers report in different currencies, so total liabilities is compared through growth and share of total assets rather than absolute size.
  • Total liabilities amounts to 11.3% of total assets for AGMB, versus a peer median of 23.5%.
AGMB Competitors
Total Liabilities for AGMB and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ANABAnaptysBio, Inc.Mar 2026$316.94M USD-18.3%-2.1%96.1%
ALMSAlumis Inc. Common StockJun 2026$108.46M USD-13.6%-28.6%19.3%
ACRSAclaris Therapeutics, Inc.Mar 2026$55.07M USD+1.9%+0.2%27.7%
AGMBAgomAb Therapeutics N.V. American Depositary SharesSep 2025€18.7M EUR——11.3%
EQEquillium, Inc.Mar 2026$3.6M USD-41.5%-58.6%5.7%
ODTXOdyssey Therapeutics, Inc.—— ———
Peer median (excluding AGMB) —-16.0%-15.3%23.5%

Competitors are the stored peer set for AGMB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

AgomAb Therapeutics N.V. American Depositary Shares

NASDAQ:AGMB

Intrinsic Alpha fair value

Locked

Current Price

$5.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.